Cardiac physiologic pacing, also known as cardiac resynchronization therapy, is indicated in patients with heart failure, reduced left ventricular ejection fraction (LVEF) of 50% or less, and either a ...
A new analysis, designed to shed light on the benefits of SGLT2 inhibition in patients who have heart failure with preserved ejection fraction (HFpEF), shows that dapagliflozin (Farxiga; AstraZeneca) ...
A new study published in the journal of Frontiers in Cardiovascular Medicine revealed that Sodium-glucose cotransporter 2 inhibitors (SGLT-2i) were associated with improved left ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
A female in her early 30s with a previous history of postpartum granulomatous hypophysitis presented with palpitations and a syncopal episode. She was haemodynamically unstable on arrival with a heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results